Erratum: Dilated thin-walled blood and lymphatic vessels in human endometrium: A potential role for VEGF-D in progestin-induced break-through bleeding (PLoS ONE (2012) 7:2 (e30916) DOI: 10.1371/journal.pone.0030916);Dilated thin-walled blood and lymphatic vessels in human endometrium: A potential role for VEGF-D in progestin-induced break-through bleeding

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Donoghue, Jacqueline F ^a   McGavigan, C Jay ^a,d   Lederman, Fiona L ^b   Cann, Leonie M ^b   Fu, Lulu ^b   Dimitriadis, Eva ^c   Girling, Jane E ^b   Rogers, Peter A W ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; VASCULOTROPIN D; LEVONORGESTREL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAKTHROUGH BLEEDING; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOMETRIUM CELL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; INTERMETHOD COMPARISON; LYMPH VESSEL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; VASODILATATION; WESTERN BLOTTING; XENOGRAFT; ADULT; ANIMAL; BIOLOGICAL MODEL; BLEEDING; DECIDUA; DRUG EFFECT; ENDOMETRIUM; METABOLISM; MOUSE MUTANT; PATHOLOGY; VASCULARIZATION;

ADULT; ANIMALS; DECIDUA; ENDOMETRIUM; FEMALE; HEMORRHAGE; HUMANS; LEVONORGESTREL; LYMPHATIC VESSELS; MICE; MICE, SCID; MODELS, BIOLOGICAL; PROGESTINS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 84857162368     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0259337     Document Type: Erratum

References (46)

1. Rodriguez MI, Warden M, Darney PD, (2010) Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications. Am J Obstet Gynecol 202: 420-428.
2. Stewart A, Cummins C, Gold L, Jordan R, Phillips W, (2001) The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. BJOG 108: 74-86.
3. Rodgers AK, Falcone T, (2008) Treatment strategies for endometriosis. Expert Opin Pharmacother 9: 243-255.
4. d'Arcangues C, (2000) Management of vaginal bleeding irregularities induced by progestin-only contraceptives. Hum Reprod 15 (Suppl 3): 24-29.
5. Findlay JK, (1996) Future directions for research on endometrial bleeding. Hum Reprod 11 (Suppl 2): 179-183.
6. Markee JE, (1978) Menstruation in intraocular endometrial transplants in the Rhesus monkey. Am J Obstet Gynecol 131: 558-559.
7. Rogers PA, (1996) Endometrial vasculature in Norplant users. Hum Reprod 11 (Suppl 2): 45-50.
8. Wonodirekso S, Affandi B, Siregar B, Barasila AC, Damayanti L, et al. (2000) Endometrial epithelial integrity and subepithelial reticular fibre expression in progestin contraceptive acceptors. Hum Reprod 15 (Suppl 3): 189-196.
9. Vincent AJ, Zhang J, Ostor A, Rogers PA, Affandi B, et al. (2002) Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum Reprod 17: 1189-1198.
10. Clark DA, Wang S, Rogers P, Vince G, Affandi B, (1996) Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant). Hum Reprod 11: 1438-1444.
11. Rogers PA, Plunkett D, Affandi B, (2000) Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding. Hum Reprod 15 (Suppl 3): 78-84.
12. Stephanie R, Labied S, Blacher S, Frankenne F, Munaut C, et al. (2007) Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Hum Reprod 22: 3084-3091.
13. Hickey M, Dwarte D, Fraser IS, (2000) Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hum Reprod 15: 1509-1514.
14. Wulff C, Weigand M, Kreienberg R, Fraser HM, (2003) Angiogenesis during primate placentation in health and disease. Reproduction 126: 569-577.
15. Volchek M, Girling JE, Lash GE, Cann L, Kumar B, et al. (2010) Lymphatics in the human endometrium disappear during decidualization. Hum Reprod 25: 2455-2464.
16. Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF, (1998) Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod 13: 1210-1217.
17. Rogers PA, Au CL, Affandi B, (1993) Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum Reprod 8: 1396-1404.
18. Song JY, Fraser IS, (1995) Effects of progestogens on human endometrium. Obstet Gynecol Surv 50: 385-394.
19. Hickey M, Fraser I, Dwarte D, Graham S, (1996) Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study. Hum Reprod 11 (Suppl 2): 35-44.
20. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, et al. (1998) Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 105: 592-598.
21. Fraser IS, Hickey M, (2000) Endometrial vascular changes and bleeding disturbances with long-acting progestins. Steroids 65: 665-670.
22. McGavigan CJ, Dockery P, Metaxa-Mariatou V, Campbell D, Stewart CJ, et al. (2003) Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel. Hum Reprod 18: 77-84.
23. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, et al. (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 92: 1098-1106.
24. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, et al. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7: 186-191.
25. Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, et al. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274: 32127-32136.
26. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, et al. (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16: 3898-3911.
27. Adams RH, Alitalo K, (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8: 464-478.
28. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K, (2000) Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 60: 203-212.
29. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, et al. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 92: 3566-3570.
30. McColl BK, Baldwin ME, Roufail S, Freeman C, Moritz RL, et al. (2003) Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med 198: 863-868.
31. Kholova I, Koota S, Kaskenpaa N, Leppanen P, Narvainen J, et al. (2007) Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle. Hum Gene Ther 18: 232-244.
32. Byzova TV, Goldman CK, Jankau J, Chen J, Cabrera G, et al. (2002) Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 99: 4434-4442.
33. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, et al. (2004) Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109: 1029-1035.
34. Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, et al. (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20: 1223-1231.
35. Girling JE, Donoghue JF, Lederman FL, Cann LM, Achen MG, et al. (2010) Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancer. Reprod Biol Endocrinol 8: 84.
36. Jones RL, Critchley HO, (2000) Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 15 (Suppl 3): 162-172.
37. Morison NB, Zhang J, Kaitu'u-Lino TJ, Fraser IS, Salamonsen LA, (2007) The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women. Reproduction 133: 309-321.
38. Yu J, Wu J, Bagchi IC, Bagchi MK, Sidell N, et al. (2011) Disruption of gap junctions reduces biomarkers of decidualization and angiogenesis and increases inflammatory mediators in human endometrial stromal cell cultures. Mol Cell Endocrinol 344: 25-34.
39. Rogers PA, Martinez F, Girling JE, Lederman F, Cann L, et al. (2005) Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding. Hum Reprod 20: 3341-3347.
40. Hickey M, Dwarte D, Fraser IS, (1998) Precise measurements of intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use. Hum Reprod 13: 3190-3196.
41. Runic R, Schatz F, Wan L, Demopoulos R, Krikun G, et al. (2000) Effects of norplant on endometrial tissue factor expression and blood vessel structure. J Clin Endocrinol Metab 85: 3853-3859.
42. Alvarez Gonzalez ML, Galant C, Frankenne F, Nisolle M, Labied S, et al. (2009) Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium. Hum Reprod 24: 697-704.
43. Alvarez Gonzalez ML, Frankenne F, Galant C, Marbaix E, Foidart JM, et al. (2009) Mixed origin of neovascularization of human endometrial grafts in immunodeficient mouse models. Hum Reprod 24: 2217-2224.
44. Cohen PE, Milligan SR, (1993) Silastic implants for delivery of oestradiol to mice. J Reprod Fertil 99: 219-223.
45. Donoghue JF, Lederman FL, Susil BJ, Rogers PA, (2007) Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod 22: 1705-1713.
46. Menkhorst E, Salamonsen LA, Zhang J, Harrison CA, Gu J, et al. (2010) Interleukin 11 and activin A synergise to regulate progesterone-induced but not cAMP-induced decidualization. J Reprod Immunol 84: 124-132.